Closing of a Seed Funding Round for Kanso Diagnostics - SMPLAW
Summary
Kanso Diagnostics closed a seed funding round with support from the Incentive incubator, Peregrine, the Israel Innovation Authority, Shaare Zedek Hospital, Beckton Dickinson, and Bristol Myers Squibb. The company plans to use the capital to accelerate its mission in molecular diagnostics. It aims to build modern diagnostic solutions that are accessible, versatile, and easy to use. The funding should help Kanso expand development of diagnostics that work anytime, anywhere, and by anyone.
Funding
Amount
None
Total raised
Date
September 1, 2024
Announcement date
Investors
Incentive, Israel Innovation Authority
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected